Category: Vaccines
Global Vaccines
-
HIV Vaccines Market by Antibodies (Dicloxacillin, Fusidic Acid Ointment, Gentamicin Ointment), Type (Acute Paronychia, Candidal Paronychia, Chronic Paronychia), Category - Global Forecast 2024-2030
... 2023 and expected to reach USD 943.11 million in 2024, at a CAGR 39.62% to reach USD 7,011.84 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the HIV Vaccines ... Read More
-
Biopharmaceutical Processing Equipment & Consumables Market by Product (Bioprocessing Containers, Bioreactors, Biosafety Cabinets), Application (Monoclonal Antibody, Vaccine), End-User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 51.25 billion in 2024, at a CAGR 9.07% to reach USD 86.18 billion by 2030. Global Biopharmaceutical Processing Equipment & Consumables Market FPNV Positioning Matrix The FPNV ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing Market by Cancer Type (Breast, Colorectal, Head and Neck), Drug Type (Immunomodulators, Monoclonal Antibodies, Oncolytic Viral Therapies & Cancer Vaccines), Service Type - Global Forecast 2024-2030
... Discovery Outsourcing Market size was estimated at USD 1.60 billion in 2023 and expected to reach USD 1.84 billion in 2024, at a CAGR 15.59% to reach USD 4.41 billion by 2030. Global Cancer Immunotherapy ... Read More
-
COVID-19 Vaccines Market by Product Type (Monovalent Vaccine, Multivalent Vaccine), End-User (Academic & Research Centers, Clinics, Hospitals), Patient Type - Global Forecast 2024-2030
... 2023 and expected to reach USD 237.12 billion in 2024, at a CAGR 10.55% to reach USD 434.83 billion by 2030. Global COVID-19 Vaccines Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Cancer Immunotherapy Drugs Market by Type (Cancer Vaccines, Checkpoint Inhibitors, Immunomodulators), Indication (Breast Cancer, Colorectal Cancer, Head & Neck Cancer), End-user - Global Forecast 2024-2030
... 215.29 billion in 2023 and expected to reach USD 243.31 billion in 2024, at a CAGR 13.10% to reach USD 509.93 billion by 2030. Global Cancer Immunotherapy Drugs Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Conjugate Vaccine Market by Type (Monovalent, Multivalent), Indication (Diphtheria & Pertussis, Influenza, Meningococcal), Pathogen Type, End-User - Global Forecast 2024-2030
... to reach USD 43.92 billion in 2024, at a CAGR 10.81% to reach USD 81.42 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Conjugate Vaccine Market. It offers ... Read More
-
Allergy Vaccine Market by Allergy Type (Allergic Asthma, Cat Dander Allergy, Grass Pollen Hypersensitivity), Vaccine Type (Cat Allergy Vaccine, House Dust Mite Allergy Vaccine, Injectable MPL Allergy Vaccine), Application, End User - Global Forecast 2024-
... The Allergy Vaccine Market size was estimated at USD 1.28 billion in 2023 and expected to reach USD 1.43 billion in 2024, at a CAGR 11.51% to reach USD 2.75 billion by 2030. FPNV Positioning ... Read More
-
Auto-disable Syringes Market by Indication (Infectious Diseases, Inflammatory/Auto-Immune Diseases), Application (Blood Collection, Drug Delivery, Vaccination), End-User - Global Forecast 2024-2030
... to reach USD 25.94 billion in 2024, at a CAGR 11.54% to reach USD 50.01 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Auto-disable Syringes Market. It offers ... Read More
-
Influenza Vaccine Market by Vaccine Type (Inactivated, Live Attenuated, Recombinant), Age Group (Adolescent Vaccination, Adult Vaccination, Infant Vaccination), Administration Route, Distribution Channel - Global Forecast 2024-2030
... 7.92 billion in 2023 and expected to reach USD 8.61 billion in 2024, at a CAGR 9.01% to reach USD 14.49 billion by 2030. Global Influenza Vaccine Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Therapeutic Vaccines Market by Vaccines Type (Auto-Immune Diseases Vaccines, Chronic Disease Vaccines, Infectious Diseases Vaccines), Disease Indication (Dengue, DTP, Hepatitis), Administration, End-User - Global Forecast 2024-2030
... 30.08 billion in 2023 and expected to reach USD 33.05 billion in 2024, at a CAGR 10.35% to reach USD 59.95 billion by 2030. Global Therapeutic Vaccines Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Therapeutic BCG Vaccines Global Market Report 2024
... National Biotec Group; Serum Institute of India Pvt. Ltd. Therapeutic BCG Vaccines Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess ... Read More
-
Adult Vaccines Global Market Report 2024
... Zoster; Pneumococcal; Hepatitis4) By End Users: Healthcare Firms; HospitalsCovering: GlaxoSmithKline PLC; Merck & Co; Sanofi Pasteur; Pfizer Inc; Commonwealth Serum Laboratories Limited Adult Vaccines Global Market Report 2024 from The Business Research Company provides strategists, ... Read More
-
Global Hepatitis B Vaccines Market Research Report 2024(Status and Outlook)
... in 2023 and is projected to reach USD 1161.93 million by 2029, exhibiting a CAGR of 1.80% during the forecast period. This report provides a deep insight into the global Hepatitis B Vaccines market covering ... Read More
-
Global Veterinary Vaccine Adjuvants Market Research Report 2024(Status and Outlook)
... are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically ... Read More
-
Global Vaccine Adjuvants Market Research Report 2024(Status and Outlook)
... substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an ... Read More
-
Global Hepatitis A Vaccination Market Research Report 2024(Status and Outlook)
... HAV infection, Minimum age for HAV vaccination is 1 year. The Global Hepatitis A Vaccination Market Size was estimated at USD 754.91 million in 2023 and is projected to reach USD 860.20 million by 2029, ... Read More
-
Global Pneumococcal Vaccination Market Research Report 2024(Status and Outlook)
... USD 4293.18 million in 2023 and is projected to reach USD 7857.97 million by 2029, exhibiting a CAGR of 10.60% during the forecast period. This report provides a deep insight into the global Pneumococcal Vaccination ... Read More
-
Global Swine Reproductive and Respiratory Syndrome Vaccine Market Research Report 2024(Status and Outlook)
... in pig population. The Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size was estimated at USD 472.35 million in 2023 and is projected to reach USD 845.97 million by 2029, exhibiting a CAGR of ... Read More
-
Global Encephalitis Vaccine Market Research Report 2024(Status and Outlook)
... infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus. ... Read More
-
Global Tick-borne Encephalitis Inactivated Vaccine Market Research Report 2024(Status and Outlook)
... The major symptoms occurring as a result of TBE infection are headache, agitation, high temperature (fever), sickness (vomiting), and confusion. The Global Tick-borne Encephalitis Inactivated Vaccine Market Size was estimated at USD 562.57 million in ... Read More
-
Global Poultry Vaccines Market Research Report 2024(Status and Outlook)
... against them. A vaccine helps to prevent a particular disease by triggering or boosting the bird’s immune system to produce antibodies that in turn fight the invading causal organisms. The Global Poultry Vaccines Market Size ... Read More
-
Global Vaccines for Fish Aquaculture Market Research Report 2024(Status and Outlook)
... stress the fish due to high stocking densities, reduced oxygen levels, sub-optimal water quality and high pathogen loads. Therefore, farmed fish, similar to farmed animals, have an increased susceptibility to infectious diseases. Such diseases may ... Read More
-
Global Duck Medicine and Vaccines Market Research Report 2024(Status and Outlook)
... at USD 678.39 million in 2023 and is projected to reach USD 914.32 million by 2029, exhibiting a CAGR of 5.10% during the forecast period. This report provides a deep insight into the global Duck ... Read More
-
Global Travel Vaccines Market Research Report 2024(Status and Outlook)
... and B, rabies, typhoid and cholera The Global Travel Vaccines Market Size was estimated at USD 5960.80 million in 2023 and is projected to reach USD 9406.61 million by 2029, exhibiting a CAGR of 7.90% ... Read More
-
Global Foot and Mouth Disease (FMD) Vaccines for Cattle Market Research Report 2024(Status and Outlook)
... (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats. The Global Foot and Mouth Disease (FMD) Vaccines for Cattle ... Read More
Research Assistance
